Skip to main content
. 2020 Jan;9(1):42–48. doi: 10.21037/tcr.2019.11.07

Table S3. The proportion of Th1, Th2, Tc1, Tc2 subpopulations in peripheral blood of malignant patients.

Patients Date (d/m/y) Th1 (%) Th2 (%) Th1/Th2 Tc1 (%) Tc2 (%) Tc1/Tc2
#1 2022/4/16 4.38 3.25 1.35 14.10 3.43 4.11
2014/6/16 5.37 3.68 1.46 21.20 3.31 6.4
#2 2014/10/15 20.60 5.41 3.81 49.40 2.63 18.8
2024/12/15 17.50 20.90 0.84 66.20 1.12 59.1
#3 2009/9/15 4.98 3.92 1.27 8.57 1.46 5.87
2013/10/15 12.30 2.76 4.46 40.60 1.45 28
#4 2009/11/15 33.90 0.51 67.1 58.00 1.65 35.2
2022/12/15 35.80 2.77 12.9 61.00 3.21 19
#5 1931/8/15 19.20 0.12 160 54.60 0.75 72.8
2026/10/15 15.50 3.74 4.14 61.20 0.87 70.3
#6 2019/4/16 14.10 1.67 8.44 67.90 0.29 235.8
2007/6/16 0.67 0.33 2 20.10 1.15 17.5
#7 16/216 26.60 2.16 12.3 69.40 2.64 26.3
2027/4/16 21.40 1.51 14.2 23.70 3.97 5.97
#8 2013/1/16 23.40 0.66 35.5 63.80 1.54 41.4
2023/5/16 8.54 3.55 2.41 13.50 0.62 21.8
#9 2007/12/15 49.20 1.08 45.6 77.20 0.16 498.1
2025/12/15 52.20 1.69 30.9 74.80 2.78 26.9
#10 2022/3/16 13.50 0.47 28.6 31.80 0.48 66.7
2018/5/16 7.79 0.71 11 15.70 3.08 5.1
#11 2007/3/16 20.40 0.68 30.1 61.00 0.92 66.7
2027/4/16 6.10 2.43 2.51 11.00 1.16 9.48
#12 2018/4/16 24.80 4.57 5.43 50.50 1.07 47.2
2027/5/16 3.33 3.57 0.93 4.88 5.05 0.97
#13 2021/3/16 8.51 3.50 2.43 38.70 1.28 30.2
2003/5/16 3.86 3.13 1.23 23.80 2.05 11.61
#14 2016/3/16 18.50 1.12 16.5 45.70 1.87 24.4
1931/5/16 6.60 3.50 1.89 19.60 3.03 6.47
#15 2024/11/15 49.60 1.96 25.3 87.00 0.30 287.1
2029/12/15 30.70 0.70 43.7 76.00 0.31 249
#16 2013/11/15 23.00 2.68 8.58 57.30 1.66 34.5
2014/1/16 31.50 0.86 36.6 56.70 0.91 62.2
#17 2014/3/16 6.15 4.66 1.32 23.50 3.59 6.55
2020/5/16 3.61 1.07 3.37 7.07 1.63 4.34
#18 2025/9/15 31.20 2.12 14.7 62.60 2.31 27.1
2010/11/15 26.50 3.78 7.01 53.20 2.95 18
2010/12/15 45.80 3.33 13.8 84.30 0.47 179
#19 2006/11/15 24.00 1.62 14.8 51.10 2.15 23.8
2008/1/16 19.60 0.97 20.3 68.90 0.10 710
2023/2/16 24.30 2.65 9.17 61.00 1.23 49.6
#20 2002/11/15 21.20 1.77 12 72.40 0.93 77.8
2021/12/15 42.40 3.13 13.5 61.80 1.84 33.6
2007/3/16 52.00 1.11 46.8 86.40 0.15 572
#21 2007/9/15 2.30 1.12 2.05 5.79 1.61 3.6
2016/10/15 4.81 10.20 0.47 40.40 5.42 7.45
2024/11/15 28.70 3.19 9 71.90 1.74 41.3
#22 2010/9/15 4.60 1.58 2.91 26.90 2.58 10.4
2023/10/15 13.40 2.46 5.45 51.30 2.33 22
2001/12/15 17.40 1.66 10.5 58.40 1.31 44.6
#23 1931/7/15 52.10 1.43 36.4 74.50 1.42 52.5
2011/9/15 4.26 4.47 1 9.68 0.60 16.1
2013/10/15 47.20 0.91 51.9 81.50 0.76 107.2
#24 2012/1/16 21.50 1.33 16.2 56.90 4.61 12.3
2009/3/16 6.47 1.20 5.39 30.50 0.49 62.63
2012/4/16 4.71 0.80 5.92 23.10 2.17 10.6
#25 2024/11/15 16.20 3.10 5.23 66.20 1.04 63.7
2020/1/16 17.50 1.43 12.2 65.70 0.41 162
2001/3/16 22.50 1.72 13.1 70.80 0.72 98.3
#26 2014/9/15 3.52 1.14 3.09 4.56 2.47 1.85
2028/10/15 32.80 2.36 13.9 32.30 7.60 4.25
2008/12/15 36.50 1.43 25.5 53.90 1.26 42.8
#27 2002/9/15 0.31 0.81 0.38 2.03 0.53 3.83
1930/10/15 9.71 5.64 1.72 38.90 3.11 12.5
2029/1/16 12.50 0.67 18.5 47.60 2.39 19.9
#28 2025/12/15 9.24 1.17 7.9 46.90 0.25 186
2015/2/16 12.00 4.58 2.62 50.80 2.61 19.5
2005/5/16 9.46 3.87 2.44 20.50 2.48 8.27
#29 2024/9/15 31.00 3.10 10 53.90 4.97 10.8
2017/11/15 25.80 4.50 5.73 39.20 8.03 4.88
2024/2/16 46.60 1.25 37.3 62.10 0.67 93.1
#30 2010/10/15 28.40 2.43 11.7 65.30 1.70 38.4
2010/12/15 41.80 1.74 24 74.20 0.52 142.7
2025/2/16 35.10 1.15 30.5 60.60 0.57 106.1

Th1 cells: CD3+ CD4+ IFN-r+ IL-4-; Th2 cells: CD3+ CD4+ IL-4+ IFN-r-; Tc1cells: CD3+ CD8+ IFN-r+ IL-4-; Tc2cells: CD3+ CD8+ IL-4+ IFN-r-.